RORo: And ROR 7 are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D

FASEB Journal

Volumn 28, Issue 7, 2014, Pages 2775-2789

  Slominski, Andrzej T ^a   Kim, Tae Kang ^a   Takeda, Yukimasa ^b   Janjetovic, Zorica ^a   Brozyna, Anna A ^c   Skobowiat, Cezary ^a   Wang, Jin ^a   Postlethwaite, Arnold ^d   Li, Wei ^a   Tuckey, Robert C ^e   Jetten, Anton M ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

CYP11A1; Keratinocytes; Melanoma cells; Retinoic acid related nuclear receptors

Indexed keywords

20 HYDROXYVITAMIN D; 20,23 DIHYDROXYVITAMIN D; 5 METHOXYTRYPTAMINE; 5 METHOXYTRYPTOPHOL; 6 HYDROXYMELATONIN; CALCITRIOL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLOPHILIN B; GLUCOSE 6 PHOSPHATASE; INTERLEUKIN 17; LAMIN A; PROTEIN BMAL1; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; UNCLASSIFIED DRUG; VITAMIN D; 20 HYDROXYVITAMIN D3; 20,23 DIHYDROXYVITAMIN D3; 20,23-DIHYDROXYVITAMIN D3; 20-HYDROXYVITAMIN D3; ARNTL PROTEIN, HUMAN; CALCIFEDIOL; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE; RORA PROTEIN, HUMAN; RORC PROTEIN, HUMAN; TRANSCRIPTION FACTOR ARNTL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHO CELL LINE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MELANOMA CELL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CRICETULUS; DBA MOUSE; DRUG ANTAGONISM; GENETICS; JURKAT CELL LINE; MELANOMA; MELANOMA CELLS; METABOLISM; MOUSE; PROMOTER REGION; RETINOIC ACID-RELATED NUCLEAR RECEPTORS; TUMOR CELL LINE;

CYP11A1; KERATINOCYTES; MELANOMA CELLS; RETINOIC ACID-RELATED NUCLEAR RECEPTORS;

ANIMALS; ARNTL TRANSCRIPTION FACTORS; CALCIFEDIOL; CELL LINE, TUMOR; CELLS, CULTURED; CHO CELLS; CRICETULUS; DIHYDROXYCHOLECALCIFEROLS; FEMALE; GLUCOSE-6-PHOSPHATASE; HUMANS; INTERLEUKIN-17; JURKAT CELLS; KERATINOCYTES; MELANOMA; MICE; MICE, INBRED DBA; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PROMOTER REGIONS, GENETIC; SKIN;

EID: 84903696734     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-242040     Document Type: Article

References (70)

1. Jetten, A. M. (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal. 7, e003
2. Kurebayashi, S., Nakajima, T., Kim, S. C., Chang, C. Y., McDonnell, D. P., Renaud, J. P., and Jetten, A. M. (2004) Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma. Biochem. Biophys. Res. Commun. 315, 919-927 (Pubitemid 38249391)
3. Takeda, Y., Jothi, R., Birault, V., and Jetten, A. M. (2012) RORgamma directly regulates the circadian expression of clock genes and downstream targets in vivo. Nucleic Acids Res. 40, 8519-8535
4. Kallen, J. A., Schlaeppi, J. M., Bitsch, F., Geisse, S., Geiser, M., Delhon, I., and Fournier, B. (2002) X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 10, 1697-1707 (Pubitemid 35452576)
5. Solt, L. A., and Burris, T. P. (2012) Action of RORs and their ligands in (patho)physiology. Trends Endocrinol. Metab. 23, 619-627
6. Huh, J. R., and Littman, D. R. (2012) Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications. Eur. J. Immunol. 42, 2232-2237
7. Marciano, D. P., Chang, M. R., Corzo, C. A., Goswami, D., Lam, V. Q., Pascal, B. D., and Griffin, P. R. (2014) The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARgamma, RORs, and Rev-erbs. Cell Metab. 19, 193-208
8. Jetten, A. M., Kang, H. S., and Takeda, Y. (2013) Retinoic acid-related orphan receptors alpha and gamma: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivity. Front. Endocrinol. (Lausanne) 4, 1
9. Kallen, J., Schlaeppi, J. M., Bitsch, F., Delhon, I., and Fournier, B. (2004) Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2 A. J. Biol. Chem. 279, 14033-14038 (Pubitemid 38468938)
10. Wang, Y., Kumar, N., Crumbley, C., Griffin, P. R., and Burris, T. P. (2010) A second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hy-droxycholesterol (cerebrosterol). Biochim. Biophys. Acta 1801, 917-923
11. Wang, Y., Kumar, N., Solt, L. A., Richardson, T. I., Helvering, L. M., Crumbley, C., Garcia-Ordonez, R. D., Stayrook, K. R., Zhang, X., Novick, S., Chalmers, M. J., Griffin, P. R., and Burris, T. P. (2010) Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated ste-rol ligands. J. Biol. Chem. 285, 5013-5025
12. Jin, L., Martynowski, D., Zheng, S., Wada, T., Xie, W., and Li, Y. (2010) Structural basis for hydroxycholesterols as natural li-gands of orphan nuclear receptor RORgamma. Mol. Endocrinol. 24, 923-929
13. Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., and Steketee, J. D. (2012) Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv. Anat. Embryol. Cell Biol. 212, v, vii, 1-115
14. Elias, P. M., Williams, M. L., Choi, E. H., and Feingold, K. R. (2014) Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis. Biochim. Biophys. Acta 1841, 353-361
15. Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., and Tuckey, R. C. (2013) Steroidogenesis in the skin: Implications for local immune functions. J. Steroid Biochem. Mol. Biol. 137, 107-123
16. Bikle, D. D. (2011) Vitamin D: an ancient hormone. Exp. Dermatol. 20, 7-13
17. Holick, M. F. (2003) Vitamin D: a millenium perspective. J. Cell. Biochem. 88, 296-307 (Pubitemid 36119902)
18. Hyter, S., and Indra, A. K. (2013) Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis. FEBS Lett. 587, 529-541
19. Schmuth, M., Jiang, Y. J., Dubrac, S., Elias, P. M., and Feingold, K. R. (2008) Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J. Lipid Res. 49, 499-509
20. Bikle, D. D. (2011) The vitamin D receptor: a tumor suppressor in skin. Discov. Med. 11, 7-17
21. Slominski, A., Wortsman, J., and Tobin, D. J. (2005) The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J. 19, 176-194 (Pubitemid 40189259)
22. Wiesenberg, I., Missbach, M., Kahlen, J. P., Schrader, M., and Carlberg, C. (1995) Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23, 327-333
23. Slominski, R. M., Reiter, R. J., Schlabritz-Loutsevitch, N., Ostrom, R. S., and Slominski, A. T. (2012) Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol. Cell. Endocrinol. 351, 152-166
24. Hill, S. M., Frasch, T., Xiang, S., Yuan, L., Duplessis, T., and Mao, L. (2009) Molecular mechanisms of melatonin anticancer effects. Integr. Cancer Ther. 8, 337-346
25. Kobayashi, H., Kromminga, A., Dunlop, T. W., Tychsen, B., Conrad, F., Suzuki, N., Memezawa, A., Bettermann, A., Aiba, S., Carlberg, C., and Paus, R. (2005) A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J. 19, 1710-1712 (Pubitemid 41429538)
26. Steinmayr, M., Andre, E., Conquet, F., Rondi-Reig, L., Delhaye-Bouchaud, N., Auclair, N., Daniel, H., Crepel, F., Mariani, J., Sotelo, C., and Becker-Andre, M. (1998) staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95, 3960-3965 (Pubitemid 28173236)
27. Slominski, A., Fischer, T. W., Zmijewski, M. A., Wortsman, J., Semak, I., Zbytek, B., Slominski, R. M., and Tobin, D. J. (2005) On the role of melatonin in skin physiology and pathology. Endocrine 27, 137-148
28. Plum, L. A., and DeLuca, H. F. (2010) Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 9, 941-955
29. Van Belle, T. L., Gysemans, C., and Mathieu, C. (2013) Vitamin D and diabetes: the odd couple. Trends Endocrinol. Metab. 24, 561-568
30. Pike, J. W., and Meyer, M. B. (2013) Fundamentals of vitamin D hormone-regulated gene expression. [E-pub ahead of print] J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2013.11.004
31. Guryev, O., Carvalho, R. A., Usanov, S., Gilep, A., and Esta-brook, R. W. (2003) A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc. Natl. Acad. Sci. U.S.A. 100, 14754-14759 (Pubitemid 37517963)
32. Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Li, W., Szczesniewski, A., and Tuckey, R. C. (2005) The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J. 272, 4080-4090 (Pubitemid 41160916)
33. Slominski, A., Semak, I., Wortsman, J., Zjawiony, J., Li, W., Zbytek, B., and Tuckey, R. C. (2006) An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-medi-ated conversion to 20-hydroxyvitamin D2 and 17, 20-dihydroxyvi-tamin D2. FEBS J. 273, 2891-2901
34. Tuckey, R. C., Li, W., Zjawiony, J. K., Zmijewski, M. A., Nguyen, M. N., Sweatman, T., Miller, D., and Slominski, A. (2008) Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J. 275, 2585-2596 (Pubitemid 351600097)
35. Slominski, A. T., Kim, T.-K., Shehabi, H. Z., Semak, I., Tang, E. K. Y., Nguyen, M. N., Benson, H. A. E., Korik, E., Janjetovic, Z., Chen, J., Yates, C. R., Postlethwaite, A., Li, W., and Tuckey, R. C. (2012) In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 26, 3901-3915
36. Tuckey, R. C., Li, W., Shehabi, H. Z., Janjetovic, Z., Nguyen, M. N., Kim, T. K., Chen, J., Howell, D. E., Benson, H. A., Sweatman, T., Baldisseri, D. M., and Slominski, A. (2011) Production of 22-hydroxy metabolites of vitamin d3 by cyto-chrome p450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab. Dispos. 39, 1577-1588
37. Slominski, A. T., Kim, T. K., Li, W., Yi, A. K., Postlethwaite, A., and Tuckey, R. C. (2013) The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. [E-pub ahead of print] J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2013.10.012
38. Slominski, A., Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Bhattacharya, K. G., Wang, J., Li, W., Jiao, Y., Gu, W., Brown, M., and Postlethwaite, A. E. (2013) 20S-Hydroxyvitamin D3, noncal-cemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J. Clin. Endocrinol. Metab. 98, E298-303
39. Slominski, A. T., Kim, T. K., Janjetovic, Z., Tuckey, R. C., Bieniek, R., Yue, J., Li, W., Chen, J., Nguyen, M. N., Tang, E. K., Miller, D., Chen, T. C., and Holick, M. (2011) 20-Hydroxyvita-min D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am. J. Physiol. Cell Physiol. 300, C526-C541
40. Slominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., Chen, T. C., Lozanski, G., and Holick, M. F. (2010) Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One 5, e9907
41. Wang, J., Slominski, A., Tuckey, R. C., Janjetovic, Z., Kulkarni, A., Chen, J., Postlethwaite, A. E., Miller, D., and Li, W. (2012) 20-hydroxyvitamin D inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer. Res. 32, 739-746
42. Slominski, A. T., Kim, T. K., Shehabi, H. Z., Tang, E. K., Benson, H. A., Semak, I., Lin, Z., Yates, C. R., Wang, J., Li, W., and Tuckey, R. C. (2014) In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratino-cytes, Caco-2 colon cells and the adrenal gland. Mol. Cell. Endocrinol. 383, 181-192
43. Brozyna, A. A., Jozwicki, W., Janjetovic, Z., and Slominski, A. T. (2013) Expression of the vitamin D-activating enzyme 1alpha-hydroxylase (CYP27B1) decreases during melanoma progression. Hum. Pathol. 44, 374-387
44. Brozyna, A. A., Jozwicki, W., Janjetovic, Z., and Slominski, A. T. (2011) Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum. Pathol. 42, 618-631
45. Skobowiat, C., Dowdy, J. C., Sayre, R. M., Tuckey, R. C., and Slominski, A. (2011) Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am. J. Physiol. Endocrinol. Metab. 301, E484-493
46. Skobowiat, C., Sayre, R. M., Dowdy, J. C., and Slominski, A. T. (2013) Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. Br. J. Dermatol. 168, 595-601
47. Slominski, A. T., Kim, T. K., Chen, J., Nguyen, M. N., Li, W., Yates, C. R., Sweatman, T., Janjetovic, Z., and Tuckey, R. C. (2012) Cytochrome P450scc-dependent metabolism of 7-dehy-drocholesterol in placenta and epidermal keratinocytes. Int. J. Biochem. Cell Biol. 44, 2003-2018
48. Jetten, A. M., Kurebayashi, S., and Ueda, E. (2001) The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog. Nucleic Acids Res. Mol. Biol. 69, 205-247 (Pubitemid 33804679)
49. Takeda, Y., and Jetten, A. M. (2013) Prospero-related homeobox 1 (Prox1) functions as a novel modulator of retinoic acid-related orphan receptors alpha-and gamma-mediated transactivation. Nucleic Acids Res. 41, 6992-7008
50. Nguyen, M. N., Slominski, A., Li, W., Ng, Y. R., and Tuckey, R. C. (2009) Metabolism of vitamin d2 to 17, 20, 24-trihydroxyvitamin d2 by cytochrome p450scc (CYP11A1). Drug Metab. Dispos. 37, 761-767
51. Kim, T. K., Kleszczynski, K., Janjetovic, Z., Sweatman, T., Lin, Z., Li, W., Reiter, R. J., Fischer, T. W., and Slominski, A. T. (2013) Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J. 27, 2742-2755
52. Slominski, A. T., Li, W., Bhattacharya, S. K., Smith, R. A., Johnson, P. L., Chen, J., Nelson, K. E., Tuckey, R. C., Miller, D., Jiao, Y., Gu, W., and Postlethwaite, A. E. (2011) Vitamin D analogs 17, 20S(OH)2pD and 17, 20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J. Invest. Dermatol. 131, 1167-1169
53. Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Thorpe, E. M., Jr., and Slominski, A. T. (2010) 20, 23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J. Cell. Physiol. 223, 36-48
54. Slominski, A. T., Janjetovic, Z., Kim, T. K., Wright, A. C., Grese, L. N., Riney, S. J., Nguyen, M. N., and Tuckey, R. C. (2012) Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes. Anticancer Res. 32, 3733-3742
55. Antonov, J., Goldstein, D. R., Oberli, A., Baltzer, A., Pirotta, M., Fleischmann, A., Altermatt, H. J., and Jaggi, R. (2005) Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab. Invest. 85, 1040-1050 (Pubitemid 41486428)
56. Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., Watowich, S. S., Tian, Q., Jetten, A. M., and Dong, C. (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29-39
57. Chen, J., Li, C. M., Wang, J., Ahn, S., Wang, Z., Lu, Y., Dalton, J. T., Miller, D. D., and Li, W. (2011) Synthesis and antiprolif-erative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization. Bioorg. Med. Chem. 19, 4782-4795
58. Myers, L. K., Rosloniec, E. F., Cremer, M. A., and Kang, A. H. (1997) Collagen-induced arthritis, an animal model of autoim-munity. Life Sci. 61, 1861-1878 (Pubitemid 27461519)
59. Brand, D. D., Myers, L. K., Whittington, K. B., Latham, K. A., Stuart, J. M., Kang, A. H., and Rosloniec, E. F. (2002) Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J. Immunol. 168, 490-498 (Pubitemid 34014153)
60. Takeda, Y., Kang, H. S., Angers, M., and Jetten, A. M. (2011) Retinoic acid-related orphan receptor gamma directly regulates neuronal PAS domain protein 2 transcription in vivo. Nucleic Acids Res. 39, 4769-4782
61. Peiser, M. (2013) Role of Th17 cells in skin inflammation of allergic contact dermatitis. Clin. Dev. Immunol. 2013, 261037.
62. Mohan, V., Gibbs, A. C., Cummings, M. D., Jaeger, E. P., and DesJarlais, R. L. (2005) Docking: successes and challenges. Curr. Pharm. Des. 11, 323-333 (Pubitemid 40277860)
63. Zbytek, B., Janjetovic, Z., Tuckey, R. C., Zmijewski, M. A., Sweatman, T. W., Jones, E., Nguyen, M. N., and Slominski, A. T. (2008) 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxy-lation by cytochrome P450scc, stimulates keratinocyte differentiation. J. Invest. Dermatol. 128, 2271-2280
64. Palmer, M. T., Lee, Y. K., Maynard, C. L., Oliver, J. R., Bikle, D. D., Jetten, A. M., and Weaver, C. T. (2011) Lineage-specific effects of 1, 25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J. Biol. Chem. 286, 997-1004
65. Carlberg, C. (2000) Gene regulation by melatonin. Ann. N. Y. Acad. Sci. 917, 387-396
66. Fischer, T. W., Zmijewski, M. A., Zbytek, B., Sweatman, T. W., Slominski, R. M., Wortsman, J., and Slominski, A. (2006) Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int. J. Oncol. 29, 665-672
67. Elias, P. M. (2012) Structure and function of the stratum corneum extracellular matrix. J. Invest. Dermatol. 132, 2131-2133
68. Slominski, A. T., Zmijewski, M. A., Semak, I., Zbytek, B., Pisarchik, A., Li, W., Zjawiony, J., and Tuckey, R. C. (2014) Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med. Chem. 14, 77-96
69. Dai, J., Brooks, Y., Lefort, K., Getsios, S., and Dotto, G. P. (2013) The retinoid-related orphan receptor RORalpha promotes ker-atinocyte differentiation via FOXN1. PLoS One 8, e70392
70. Holick, M. F. (2007) Vitamin D deficiency. N. Engl. J. Med. 357, 266-281